Table 1.
Group | p-Akt | t-Akt | PI3K |
---|---|---|---|
| |||
C | 26.3±1.5 | 33.0±3.0 | 26.3±3.1 |
P | 16.7±2.1# | 30.7±1.5 | 12.2±2.1# |
R | 36±1.7 | 32.3±1.3 | 34.7±3.2 |
P+R | 19.3±2.0& | 32.3±2.0 | 20.7±2.1& |
LY + R+P | 8.4±1.4* | 33.0±1.5 | 9.0±2.0* |
Note: Compared with C group,
P<0.05; compared with P group,
P<0.05; compared with P+R group,
P <0.05.
Abbreviations: C, control group; R, resveratrol group; P, paclitaxel-treated group; R+P, resveratrol + paclitaxel-treated group; LY, LY294002 group; PI3K, phosphoinositide 3-kinase.